^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ifabotuzumab (KB004)

    i
    Other names: KB004 , KB-004
    Company:
    Humanigen, Olivia Newton-John Cancer Research Institute, Taran Therapeutics
    Drug class:
    EphA3 inhibitor